SCHEMBL14638499

SCHEMBL14638499

Cc1cc(/C(F)=C/c2ccc([Si](C)(C)C)cc2)nn1Cc1ccc(Cl)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
KMT2A Q03164 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.33
ATM Q13315 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
KCNK3 O14649 1/20 0.33
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
THRB P10828 1/20 0.32
PTGER1 P34995 2/20 0.32
TP53 P04637 1/20 0.32
CHRM5 P08912 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14638500 1.00 LMNA (0.53) LMNAKMT2AL3MBTL1MEN1MAPT
SCHEMBL14653544 0.89 LMNA (0.52) LMNAKMT2AL3MBTL1MEN1CYP3A4
SCHEMBL15008809 0.89 LMNA (0.52) LMNAKMT2AL3MBTL1MEN1CYP3A4
SCHEMBL14637349 0.88 LMNA (0.53) LMNAKMT2AL3MBTL1MEN1MAPT
SCHEMBL14637348 0.88 LMNA (0.53) LMNAKMT2AL3MBTL1MEN1MAPT
SCHEMBL15009595 0.87 LMNA (0.52) LMNAKMT2AL3MBTL1MEN1MAPT
SCHEMBL14653599 0.87 LMNA (0.52) LMNAKMT2AL3MBTL1MEN1MAPT
SCHEMBL14637081 0.87 LMNA (0.52) LMNAKMT2AL3MBTL1MEN1MAPT
SCHEMBL14637079 0.87 LMNA (0.52) LMNAKMT2AL3MBTL1MEN1MAPT
SCHEMBL14653507 0.86 LMNA (0.49) LMNAALDH1A1CYP3A4CYP2C9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2734505-A1 3-(FLUORVINYL)PYRAZOLES AND THE USE THEREOF Bayer Intellectual Property GmbH (DE) 2014-05-28 EP disclosed
US-20130150325-A1 3-(Fluorovinyl)pyrazoles and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-06-13 US disclosed
US-20130150325-A1 3-(Fluorovinyl)pyrazoles and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-06-13 US disclosed
US-20130150325-A1 3-(Fluorovinyl)pyrazoles and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-06-13 US disclosed
WO-2013011033-A1 3-(FLUORVINYL)PYRAZOLES AND THE USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150325-A1 3-(Fluorovinyl)pyrazoles and their use VHL, HIF1AN, HIF1A LMNA 3030/4885KMT2A 2770/4885L3MBTL1 3771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.